Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages

  Bellanné Chantelot, Christine ^a   Lévy, David Joseph ^b   Carette, Claire ^b   Saint Martin, Cécile ^a   Riveline, Jean Pierre ^c   Larger, Etienne ^d   Valéro, René ^e   Gautier, Jean François ^f   Reznik, Yves ^g   Sola, Agnès ^d   Hartemann, Agnès ^a   Laboureau Soares, Sandrine ^h   Laloi Michelin, Marie ⁱ   Lecomte, Pierre ^j   Chaillous, Lucy ^k   Dubois Laforgue, Danièle ^b   Timsit, José ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b University René Descartes Paris 5 ^*  (France)

^c CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^d HÔTEL DIEU   (France)

^e TIMONE HOSPITAL   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g CHU CÔTE DE NACRE   (France)

^h ANGERS UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

^j CHU BRETONNEAU   (France)

^k NANTES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHILD; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC ANALYSIS; GENETIC DISORDER; GEOGRAPHIC ORIGIN; HNF1A GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; MODEL; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYMPTOM; VALIDATION STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC MARKERS; GENETIC TESTING; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79961222235     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0268     Document Type: Article

References (20)

1. Frayling TM, Bulamn MP, Ellard S, Appleton M, Dronsfield MJ, Mackie AD, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, Bain SC, Hattersley AT 1997 Mutations in the hepatocyte nuclear factor-1α gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 46:720-725 (Pubitemid 27143394)
2. Fajans SS, Bell GI, Polonsky KS 2001 Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971-980
3. Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Hattersley AT 2002 Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1α gene mutation carriers. Diabetes Care 25:2287-2291 (Pubitemid 41071042)
4. Harries LW, Ellard S, Stride A, Morgan NG, Hattersley AT 2006 Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1α show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum Mol Genet 15:2216-2224 (Pubitemid 43985513)
5. Bellanné-Chantelot C, Carette C, Riveline JP, Valero R, Gautier JF, Larger E, Reznik Y, Ducluzeau PH, Sola A, Hartemann-Heurtier A, Lecomte P, Chaillous L, Laloi-Michelin M, Wilhem JM, Cuny P, Duron F, Guerci B, Jeandidier N, Mosnier-Pudar H, Assayag M, Dubois-Laforgue D, Velho G, Timsit J 2008 The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes 57:503-508
6. Lango Allen H, Johansson S, Ellard S, Shields B, Hertel JK, Raeder H, Colclough K, Molven A, Frayling TM, Njølstad PR, Hattersley AT, Weedon MN 2010 Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes. Diabetes 59:266-271
7. Ellard S, Bellanné-Chantelot C, Hattersley AT 2008 Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51:546-553
8. Murphy R, Ellard S, Hattersley AT 2008 Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nat Clin Pract Endocrinol Metab 4:200-213 (Pubitemid 351430925)
9. Cheurfa N, Dubois-Laforgue D, Ferrarezi DA, Reis AF, Brenner GM, Bouché C, Le Feuvre C, Fumeron F, Timsit J, Marre M, Velho G 2008 The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men. Diabetes 57:1063-1068
10. Carette C, Dubois-Laforgue D, Saint-Martin C, Clauin S, Beaufils S, Larger E, Sola A, Mosnier-Pudar H, Timsit J, Bellanné-Chantelot C 2010 Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies. Diabet Med 27:1454-1458
11. Hastie T, Tibshirani R, Friedman JH 2009 The elements of statistical learning: data mining, inference, and prediction. New York: Springer
12. Pearson ER, Pruhova S, Tack CJ, Johansen A, Castleden HA, Lumb PJ, Wierzbicki AS, Clark PM, Lebl J, Pedersen O, Ellard S, Hansen T, Hattersley AT 2005 Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4α mutations in a large European collection. Diabetologia 48:878-885 (Pubitemid 40767980)
13. Pruhova S, Ek J, Lebl J, Sumnik Z, Saudek F, Andel M, Pedersen O, Hansen T 2003 Genetic epidemiology of MODY in the Czech Republic: new mutations in the MODY genes HNF-4α, GCK and HNF-1α. Diabetologia 46:291-295 (Pubitemid 36343895)
14. Johansen A, Ek J, Mortensen HB, Pedersen O, Hansen T 2005 Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1. J Clin Endocrinol Metab 90:4607-4614 (Pubitemid 41159350)
15. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S 2010 Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504-2508
16. Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT 2000 Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1α gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 17:543-545 (Pubitemid 30660158)
17. Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT 2009 A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 26:437-441
18. Klupa T, Warram JH, Antonellis A, Pezzolesi M, Nam M, Malecki MT, Doria A, Rich SS, Krolewski AS 2002 Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1α mutations: evidence for parent-of-origin effect. Diabetes Care 25:2292-2301
19. Gale EA 2007 To boldly go-or to go too boldly? The accelerator hypothesis revisited. Diabetologia 50:1571-1575 (Pubitemid 47036666)
20. Owen KR, Thanabalasingham G, James TJ, Karpe F, Farmer AJ, McCarthy MI, Gloyn AL 2010 Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care 33: 1919-1924